Praxsyn Corporation (PXYN) 0.0019 $PXYN Letter to

New Post Public Reply Private Reply Replies (0) Message Board

Jun 20, 2016 at 3:08 PM

Praxsyn Corporation (PXYN) 0.0019 $PXYN

Letter to Praxsyn Corporation's Shareholders from its Chairman and CEO
GlobeNewswire - Fri Apr 15, 1:28PM CDT
Praxsyn Corporation (OTCQB

XYN) announces today it will publish a Letter to its shareholders from its Chairman and CEO regarding the company's business and operations.

Technical Data and the Price Movement -- Analyst Review of Praxsyn, Baristas Coffee Company, Soligenix and Acacia Diversified Holdings
ACCESSWIRE - Mon Feb 01, 8:20AM CST
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Praxsyn Corp. (OTC: PXYN), Baristas Coffee Company Inc. (OTC: BCCI), Soligenix Inc. (OTC: SNGX) and Acacia Diversified Holdings Inc. (OTC: ACCA). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Market Influences That Drive Equities Forward - New Research on American Green, Praxsyn, Norsk Hydro and Soligenix
ACCESSWIRE - Thu Jan 21, 8:03AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: American Green Inc. (OTC: ERBB), Praxsyn Corp. (OTC: PXYN), Norsk Hydro ASA (OTC: NHYDY) and Soligenix Inc. (OTC: SNGX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Praxsyn Corporation Launches New Website
GlobeNewswire - Mon Sep 21, 7:04PM CDT
Praxsyn Corporation (OTCQB

XYN), a diversified holding company that finds alternative solutions to fit the needs and goals of their strategic relationships, is pleased to announce the launch of its new website www.praxsyn.com. According to Edward Kurtz, CEO of Praxsyn, the new website is aimed at highlighting the company's strategic vision for growth and expansion over the next few years, and beyond.

Praxsyn Corporation Announces New Chief Financial Officer
GlobeNewswire - Mon Jul 27, 9:10AM CDT
Praxsyn Corporation's (OTCQB

XYN) today announced that Justin Cary, 33, has been appointed by the Board of Directors as the company's Chief Financial Officer (CFO) effective immediately.

Praxsyn Corporation Growth Requires Expansion Into New Space
GlobeNewswire - Thu Jul 16, 9:04AM CDT
Praxsyn Corporation (OTCQB

XYN) is pleased to announce that it has finalized a lease on a new building for its pharmacy lab and billing services with expansion efforts now underway. The new space will allow Praxsyn's wholly owned subsidiary, Mesa Pharmacy (Mesa), a medication and service provider for medical practitioners, to significantly increase the size of its pharmacy lab, providing capacity for new equipment, a more diverse list of offered medications, and to continue the growth of its pharmacy staff. The expansion will also provide additional space for another wholly-owned subsidiary, NexGen Med Solutions (NexGen), a billing and collections company.

Praxsyn's 2015 Anticipated Business Strategies
GlobeNewswire - Mon Jun 08, 12:03PM CDT
Praxsyn Corporation's (OTCQB

XYN) anticipated business plan for 2015 is to acquire a sister subsidiary retail community pharmacy and to purchase additional pharmacies. Mesa is also in the early stages of developing a program to supply medications and products to diabetic patients and anticipates the commencement of filling prescriptions by the end of the third quarter of 2015.

Praxsyn Announces New Business Associate Agreement With Products for Doctors
GlobeNewswire - Tue Apr 14, 8:15AM CDT
Praxsyn Corporation's (OTCQB

XYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), entered into a Business Associate Agreement with Products for Doctors for marketing and other services on January 23, 2015. The non-exclusive agreement between Products for Doctors and Mesa facilitates the marketing of Mesa's products to medical providers throughout California.

Praxsyn Announces New Pharmacist in Charge for Mesa Pharmacy
GlobeNewswire - Mon Mar 09, 1:55PM CDT
Praxsyn Corporation's (OTCQB

XYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), announced today that, as of February 12, 2015, Dr. Amy Lee (Hawkins) Summers, Pharm, D., has joined the company as its new pharmacist in charge (PIC) and director of pharmacy.

Praxsyn Corporation Announces Mesa Pharmacy Has Commenced Processing of PPO Prescriptions
GlobeNewswire - Thu Dec 18, 11:56AM CST
Praxsyn Corporation (OTCQB

XYN), the parent company of Mesa Pharmacy, today announced that it has begun to process PPO prescriptions. Mesa Pharmacy is dedicated to providing medical practitioners with medications for patients through this move into the PPO network with its new and advanced products.

Praxsyn Corporation Now Licensed to Dispense Medication in 22 States
GlobeNewswire - Fri Dec 12, 9:02AM CST
Praxsyn Corporation (OTCQB

XYN), today announced that its wholly owned subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, has continued to make progress towards its goal of dispensing its customized medications nationwide. "We believe in our products and we are excited to help patients nationwide," said Andrew Do, Chief Pharmacist, Mesa Pharmacy. The company is now licensed to dispense its medications in the following 22 states:

Praxsyn Corporation Announces Change of Domicile From Illinois to Nevada and Appointment of New Board Members
GlobeNewswire - Wed Nov 05, 8:30AM CST
Praxsyn Corporation (OTCQB

XYN) announced today that the majority of its shareholders have voted to change domiciles from the state of Illinois to Nevada. Praxsyn Corporation shareholders entitled to vote authorized the change of domicile via their majority written consent due to: a) Nevada's favorable corporate laws; b) lower corporate income taxes; and c) easily accessible corporate filings through the Nevada Secretary of State's web portal.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aspen Dental Brings Comprehensive Care to Whiteville

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Striveworks: Boosting Army's AI Edge in Indo-Pacific

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

PrideStaff: 8 Years Strong on Franchise Times Top 400

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Webull Faces Legal Scrutiny Over Chinese Ties

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Lupin Secures FDA Nod for Key Injectable Drug

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Raken Debuts Change Orders: A Game-Changer for Builds

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Hexaware Teams with Anthropic for Game-Changing AI Move

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Ajman Tourism Department Hits Internal Audit Milestone

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Rutter Mills Secures $13M in Virginia Injury Cases

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Ardelyx Securities Fraud Suit: Key Investor Moves

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...